Business · 19/05/2015Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Regulations for In Vivo Radiopharmaceuticals
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to the use of in vivo radiopharmaceuticals for diagnosis and monitoring, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →